Effects of Zibotentan Alone and in Combination with Dapagliflozin on Fluid Retention in Patients with CKD.
J David SmeijerVictor S WasehuusNeeraj DhaunJose Luis Gorriz TeruelMaria José SolerMagnus ÅstrandAnne-Kristina MercierPeter J GreasleyPhilip AmberyHiddo J Lambers HeerspinkPublished in: Journal of the American Society of Nephrology : JASN (2024)
High doses of zibotentan were associated with a higher risk of fluid retention, which was attenuated with lower doses and the addition of dapagliflozin.
Keyphrases